CYP2S1

Revision as of 20:20, 7 January 2009 by Swilliams (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Cytochrome P450, family 2, subfamily S, polypeptide 1
Identifiers
Symbols CYP2S1 ;
External IDs Template:MGI HomoloGene75274
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

WikiDoc Resources for CYP2S1

Articles

Most recent articles on CYP2S1

Most cited articles on CYP2S1

Review articles on CYP2S1

Articles on CYP2S1 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CYP2S1

Images of CYP2S1

Photos of CYP2S1

Podcasts & MP3s on CYP2S1

Videos on CYP2S1

Evidence Based Medicine

Cochrane Collaboration on CYP2S1

Bandolier on CYP2S1

TRIP on CYP2S1

Clinical Trials

Ongoing Trials on CYP2S1 at Clinical Trials.gov

Trial results on CYP2S1

Clinical Trials on CYP2S1 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CYP2S1

NICE Guidance on CYP2S1

NHS PRODIGY Guidance

FDA on CYP2S1

CDC on CYP2S1

Books

Books on CYP2S1

News

CYP2S1 in the news

Be alerted to news on CYP2S1

News trends on CYP2S1

Commentary

Blogs on CYP2S1

Definitions

Definitions of CYP2S1

Patient Resources / Community

Patient resources on CYP2S1

Discussion groups on CYP2S1

Patient Handouts on CYP2S1

Directions to Hospitals Treating CYP2S1

Risk calculators and risk factors for CYP2S1

Healthcare Provider Resources

Symptoms of CYP2S1

Causes & Risk Factors for CYP2S1

Diagnostic studies for CYP2S1

Treatment of CYP2S1

Continuing Medical Education (CME)

CME Programs on CYP2S1

International

CYP2S1 en Espanol

CYP2S1 en Francais

Business

CYP2S1 in the Marketplace

Patents on CYP2S1

Experimental / Informatics

List of terms related to CYP2S1

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cytochrome P450, family 2, subfamily S, polypeptide 1, also known as CYP2S1, is a human gene.[1]

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. In rodents, the homologous protein has been shown to metabolize certain carcinogens; however, the specific function of the human protein has not been determined.[1]

References

  1. 1.0 1.1 "Entrez Gene: CYP2S1 cytochrome P450, family 2, subfamily S, polypeptide 1".

Further reading

  • Adams MD, Kerlavage AR, Fleischmann RD; et al. (1995). "Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence". Nature. 377 (6547 Suppl): 3–174. PMID 7566098.
  • Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M (2001). "Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1)". Biochem. Biophys. Res. Commun. 281 (2): 529–35. doi:10.1006/bbrc.2001.4390. PMID 11181079.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Smith G, Wolf CR, Deeni YY; et al. (2003). "Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases". Lancet. 361 (9366): 1336–43. PMID 12711469.
  • Saito S, Iida A, Sekine A; et al. (2003). "Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population". J. Hum. Genet. 48 (5): 249–70. doi:10.1007/s10038-003-0021-7. PMID 12721789.
  • Clark HF, Gurney AL, Abaya E; et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMID 12975309.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Rivera SP, Wang F, Saarikoski ST; et al. (2007). "A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia". J. Biol. Chem. 282 (15): 10881–93. doi:10.1074/jbc.M609617200. PMID 17277313.
  • Marek CJ, Tucker SJ, Koruth M; et al. (2007). "Expression of CYP2S1 in human hepatic stellate cells". FEBS Lett. 581 (4): 781–6. doi:10.1016/j.febslet.2007.01.056. PMID 17280660.
  • Hanzawa Y, Sasaki T, Hiratsuka M; et al. (2007). "Three novel single nucleotide polymorphisms (SNPs) of CYP2S1 gene in Japanese individuals". Drug Metab. Pharmacokinet. 22 (2): 136–40. PMID 17495422.
  • Jang YJ, Cha EY, Kim WY; et al. (2007). "CYP2S1 gene polymorphisms in a Korean population". Therapeutic drug monitoring. 29 (3): 292–8. doi:10.1097/FTD.0b013e318058a4e0. PMID 17529885.

Template:SIB

Template:WH Template:WikiDoc Sources